INVITATION TO TELEPHONE CONFERENCE

INVITATION TO TELEPHONE CONFERENCE

Elekta will publish its three months interim report 2008/09 on Thursday
September 18 at around 13.00 CET and a telephone conference will be held the
following day, Friday September 19, at 10.00 CET.

Tomas Puusepp, President and CEO, and Håkan Bergström, CFO, will comment the
first quarter results and answer questions. 

To take part in the conference call, please dial in about five minutes in
advance. You will be placed in a so-called waiting room until the chairman has
declared the meeting opened.

Call-in numbers for teleconference, September 19 at 10.00 CET
UK:		+44 (0)20 7162 0025 
US:		+1 334 323 6201 
Norway:		+47 2156 312 0 
France:		+33 (0)1 7099 3208 
Germany:		+49 (0)695 8999 0507 
Netherlands:	+31 (0)20 7965 008 
Sweden:		+46 (0)8 5052 0110 
Denmark:		+45 3271 4607 
Switzerland (Geneva):	+41 (0)2 2592 7007 
Switzerland (Zurich):	+41 (0)434 5692 61

Please note that for local connect dial-in numbers it may be required to dial
the area code to enter the conference.

The teleconference will also be broadcasted over the Internet (audio only).
Please visit www.elekta.com - Investors, or use the direct link:
http://wcc.webeventservices.com/view/wl/r.htm?e=117926&s=1&k=B4B7CF61FBA2C2945A1
14DF02EDF6264&cb=genesys

The telephone conference will be available afterwards on instant replay for
seven days. Please dial U.K. +44 (0)207 031 40 64, Sweden +46 (0) 8 505 203 33,
US +1 954 334 03 42 and use access code 807583.


For further information, please contact:
Lena Schattauer, Investor Relations, Elekta AB
Tel: +46 8 587 257 22, +46 70 595 51 00, e-mail: lena.schattauer@elekta.com 


About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state-of-the-art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems, as well as services for improved cancer care and management
of brain disorders.

Elekta's systems and solutions are used in over 5,000 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery, and the MOSAIQ® suite of software for image enabled EMR and
efficient management of clinical and patient data.

With approximately 2,400 employees globally, the corporate headquarters are
located in Stockholm, Sweden and the company is listed on the Nordic Exchange
under the ticker EKTAb. More information about Elekta can be found at
www.elekta.com